Egyptian Association of Vascular Biology and Atherosclerosis inhibitors
Egyptian Association of Vascular Biology and Atherosclerosis inhibitors
About this item
Full title
Egyptian Association of Vascular Biology and Atherosclerosis inhibitors
Author / Creator
Publisher
Springer
Journal title
The Egyptian heart journal, 2020-05, Vol.72 (1)
Language
English
Formats
Publication information
Publisher
Springer
Subjects
More information
Scope and Contents
Contents
Background The current expert view of the PCSK9 inhibitors' use in Egypt is still ambiguous. Main body Hyperlipidemia is an important, if not the most important, risk factor for the occurrence of atherosclerosis worldwide. Egypt is the most populous country in the Middle East and North Africa and has > 15% of the cardiovascular deaths in the region...
Alternative Titles
Full title
Egyptian Association of Vascular Biology and Atherosclerosis inhibitors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A680161035
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A680161035
Other Identifiers
ISSN
1110-2608
DOI
10.1186/s43044-020-00058-0
How to access this item
Log in as a Library member
